Search research articles
Contact Us
Filters
Showing results (231-240 of 359) with videos related to
Page
of 36
Sort By:
Scientific Reports
|
September 24, 2022
Lead-exposure associated miRNAs in humans and Alzheimer's disease as potential biomarkers of the disease and disease processes
Qingfeng Wen, Marcha Verheijen, Mandy Melissa Jane Wittens, et al.
The Journal of Biological Chemistry
|
December 26, 2014
Tau monoclonal antibody generation based on humanized yeast models: impact on Tau oligomerization and diagnostics
Joëlle Rosseels, Jeff Van den Brande, Marie Violet, et al.
Acta Neuropathologica Communications
|
February 13, 2021
Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson's disease
Stefanie Smolders, Stéphanie Philtjens, David Crosiers, et al.
Neurobiology of Aging
|
December 11, 2007
Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS
Ilse Gijselinck, Kristel Sleegers, Sebastiaan Engelborghs, et al.
Frontiers in Aging Neuroscience
|
December 16, 2022
Predicting AT(N) pathologies in Alzheimer's disease from blood-based proteomic data using neural networks
Yuting Zhang, Upamanyu Ghose, Noel J Buckley, et al.
Journal of Alzheimer'S Disease : JAD
|
September 24, 2016
Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization
Piotr Lewczuk, Natalia Lelental, Ingolf Lachmann, et al.
Alzheimer'S Research & Therapy
|
July 16, 2017
No added diagnostic value of non-phosphorylated tau fraction (p-tau<sub>rel</sub>) in CSF as a biomarker for differential dementia diagnosis
Joery Goossens, Maria Bjerke, Hanne Struyfs, et al.
Brain : a Journal of Neurology
|
August 8, 2007
A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder
Veerle Bogaerts, Sebastiaan Engelborghs, Samir Kumar-Singh, et al.
Brain : a Journal of Neurology
|
February 24, 2006
A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD
Julie van der Zee, Rosa Rademakers, Sebastiaan Engelborghs, et al.
Alzheimer'S Research & Therapy
|
January 27, 2018
Extended FTLD pedigree segregating a Belgian GRN-null mutation: neuropathological heterogeneity in one family
Anne Sieben, Sara Van Mossevelde, Eline Wauters, et al.
Page
of 36
Search research articles
Search
Showing results (231-240 of 359) with videos related to
Sort By:
Page
of 36
Scientific Reports
|
September 24, 2022
Lead-exposure associated miRNAs in humans and Alzheimer's disease as potential biomarkers of the disease and disease processes
Qingfeng Wen, Marcha Verheijen, Mandy Melissa Jane Wittens, et al.
The Journal of Biological Chemistry
|
December 26, 2014
Tau monoclonal antibody generation based on humanized yeast models: impact on Tau oligomerization and diagnostics
Joëlle Rosseels, Jeff Van den Brande, Marie Violet, et al.
Acta Neuropathologica Communications
|
February 13, 2021
Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson's disease
Stefanie Smolders, Stéphanie Philtjens, David Crosiers, et al.
Neurobiology of Aging
|
December 11, 2007
Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS
Ilse Gijselinck, Kristel Sleegers, Sebastiaan Engelborghs, et al.
Frontiers in Aging Neuroscience
|
December 16, 2022
Predicting AT(N) pathologies in Alzheimer's disease from blood-based proteomic data using neural networks
Yuting Zhang, Upamanyu Ghose, Noel J Buckley, et al.
Journal of Alzheimer'S Disease : JAD
|
September 24, 2016
Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization
Piotr Lewczuk, Natalia Lelental, Ingolf Lachmann, et al.
Alzheimer'S Research & Therapy
|
July 16, 2017
No added diagnostic value of non-phosphorylated tau fraction (p-tau<sub>rel</sub>) in CSF as a biomarker for differential dementia diagnosis
Joery Goossens, Maria Bjerke, Hanne Struyfs, et al.
Brain : a Journal of Neurology
|
August 8, 2007
A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder
Veerle Bogaerts, Sebastiaan Engelborghs, Samir Kumar-Singh, et al.
Brain : a Journal of Neurology
|
February 24, 2006
A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD
Julie van der Zee, Rosa Rademakers, Sebastiaan Engelborghs, et al.
Alzheimer'S Research & Therapy
|
January 27, 2018
Extended FTLD pedigree segregating a Belgian GRN-null mutation: neuropathological heterogeneity in one family
Anne Sieben, Sara Van Mossevelde, Eline Wauters, et al.
Page
of 36